Do Negative (124)I Pretherapy Positron Emission Tomography Scans in Patients with Elevated Serum Thyroglobulin Levels Predict Negative (131)I Posttherapy Scans?

Background: The management of patients with differentiated thyroid cancer (DTC) who have elevated serum thyroglobulin (Tg) levels and negative (131)I or (123)I scans is problematic, and the decision regarding whether or not to administer (131)I therapy (a “blind” therapy) is also problematic. While...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Khorjekar, Gauri R., Van Nostrand, Douglas, Garcia, Carlos, O'Neil, Jeffrey, Moreau, Shari, Atkins, Francis B., Mete, Mihriye, Orquiza, Michael H., Burman, Kenneth, Wartofsky, Leonard
Format: Artigo
Langue:Inglês
Publié: Mary Ann Liebert, Inc. 2014
Sujets:
Thyroid Radiology and Nuclear Medicine
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4148053/
https://ncbi.nlm.nih.gov/pubmed/24820222
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/thy.2013.0713
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires